KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Amortization of Deferred Charges: 2014-2020

Historic Amortization of Deferred Charges for Palvella Therapeutics (PVLA) over the last 1 years, with Mar 2020 value amounting to $199,000.

  • Palvella Therapeutics' Amortization of Deferred Charges was N/A to $199,000 in Q1 2020 from the same period last year, while for Mar 2020 it was $828,432, marking a year-over-year change of. This contributed to the annual value of $408,000 for FY2019, which is N/A change from last year.
  • Palvella Therapeutics' Amortization of Deferred Charges amounted to $199,000 in Q1 2020, which was down 45.52% from $365,251 recorded in Q3 2014.
  • Palvella Therapeutics' 5-year Amortization of Deferred Charges high stood at $199,000 for Q1 2020, and its period low was $199,000 during Q1 2020.
  • Moreover, its 1-year median value for Amortization of Deferred Charges was $199,000 (2020), whereas its average is $199,000.